Opinion
Video
The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD management.
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff